Mesenchymal Stem Cell Transplantation
"Mesenchymal Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of MESENCHYMAL STEM CELLS between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS).
| Descriptor ID |
D045164
|
| MeSH Number(s) |
E02.095.147.500.500.625 E04.936.225.687.625
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mesenchymal Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Mesenchymal Stem Cell Transplantation".
This graph shows the total number of publications written about "Mesenchymal Stem Cell Transplantation" by people in this website by year, and whether "Mesenchymal Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 39 | 5 | 44 |
| 2018 | 28 | 12 | 40 |
| 2019 | 12 | 4 | 16 |
| 2020 | 19 | 4 | 23 |
| 2021 | 12 | 1 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Mesenchymal Stem Cell Transplantation" by people in Profiles.
-
Visualized Analyses of Investigations Upon Mesenchymal Stem/stromal Cell-based Cytotherapy and Underlying Mechanisms for COVID-19 Associated ARDS. Curr Stem Cell Res Ther. 2022; 17(1):2-12.
-
COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods. Anticancer Agents Med Chem. 2021 10 28; 21(16):2142-2162.
-
Research Status of the Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of COVID-19-Related Pneumonia: A Systematic Review and Meta-Analysis. Stem Cells Dev. 2021 10 01; 30(19):947-969.
-
Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope. Life Sci. 2021 Nov 01; 284:119901.
-
Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application. Stem Cell Res Ther. 2021 08 23; 12(1):470.
-
Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects. Stem Cell Res Ther. 2021 08 21; 12(1):469.
-
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfus Apher Sci. 2021 Dec; 60(6):103237.
-
Mesenchymal Stem/Stromal Cells and Their Derivates in Acute Diseases: Emergency in the Post-COVID-19 Times. Int J Mol Sci. 2021 Aug 05; 22(16).
-
Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells. Front Immunol. 2021; 12:726909.
-
Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey. Stem Cell Rev Rep. 2021 10; 17(5):1917-1925.